Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

  • Daruka Mahadevan
  • , Amy Stejskal
  • , Laurence S. Cooke
  • , Ann Manziello
  • , Carla Morales
  • , Daniel O. Persky
  • , Richard I. Fisher
  • , Thomas P. Miller
  • , Wenqing Qi

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science